Clinical Trial Update: Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of JTT-705 and pravastatin 40 mg for Type II hyperlipidemia has completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• JTT-705
• Pravastatin (pravastatin)

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Type II Hyperlipidemia | Phase 2 | Status: COMPLETED